D-0303-2021 Class I Ongoing
FDA drug recall D-0303-2021 was initiated by Bryant Ranch Prepack, Inc. Dba BRP Pharmaceuticals on Jan 27, 2021 and is designated Class I. Reason for recall: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets. The recall status is ongoing. Affected quantity: 35 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 24, 2021
- Initiation Date
- Jan 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 35 bottles
Product description
Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA
Reason for recall
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.
Distribution pattern
Nationwide in the USA
Code information
a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0303-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026